Global /India /Healthcare /Drug Manufacturers - General /LASA

Lasa Supergenerics Ltd.

LASA

• NSE: LASA • Delayed

8.00INR -1.2%

0.0847 USD

As of 20 June 2026, Lasa Supergenerics Ltd. has a market cap of $4.3M USD, ranking #45055 globally and #4006 in India. It ranks #3993 in the Healthcare sector, and #1285 in the Drug Manufacturers - General industry.

Global Rank

45055

Country Rank

4006

Sector Rank

3993

Industry Rank

1285

Key Stats

Market Cap

$4.3MUSD

405.82M INR

Enterprise Value

$5.0MUSD

472.24M INR

Revenue (TTM)

$7.09MUSD

669.61M INR

EBITDA (TTM)

$589.77KUSD

55.68M INR

Net Income (TTM)

-$4.68MUSD

-442.17M INR

EBITDA Margin

8.3%

Profit Margin

-66%

PS Ratio

0.6

PB Ratio

0.7

EV/EBITDA

8.5

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Omkar Herlekar open_in_new

Employees

Founded

2016

Website

lasalabs.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-1.2%	-7.2%	36%	-12%	-24%	-14%	-55%	-67%	-90%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	LASA Lasa Supergenerics Ltd ISIN: INE670X01014 Shares Out.: Shares Outstanding: 50.101M¹ Shares Float: 30.538M² TV: TradingView: NSE: LASA SA: Stock Analysis: NSE: LASA YF: Yahoo Finance: LASA.NS GF: Google Finance: NSE: LASA BA: Barron's: LASA MS: Morningstar: XNSE: LASA	8.00 INR	TV: TradingView: NSE: LASA SA: Stock Analysis: NSE: LASA YF: Yahoo Finance: LASA.NS GF: Google Finance: NSE: LASA BA: Barron's: LASA MS: Morningstar: XNSE: LASA
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	540702 (LASA) Lasa Supergenerics Ltd ISIN: INE670X01014 TV: TradingView: BSE: LASA SA: Stock Analysis: BOM: 540702 YF: Yahoo Finance: 540702.BO GF: Google Finance: BOM: 540702 BA: Barron's: 540702 MS: Morningstar: XBOM: 540702	7.96 INR	TV: TradingView: BSE: LASA SA: Stock Analysis: BOM: 540702 YF: Yahoo Finance: 540702.BO GF: Google Finance: BOM: 540702 BA: Barron's: 540702 MS: Morningstar: XBOM: 540702

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Lasa Supergenerics Ltd.

Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products in India. It offers API bulk drug products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, ricobendazole, triciabendazole, oxfendazole, closantel base, closantel sodium dihydrate BP, nitroxynil, rafoxanide, oxyclozanide, ornidazole, halquinol, and 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use, such as potassium iodide. In addition, it exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$45.22B 4.27T INR 1M%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.38B 1.73T INR 427K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$15.17B 1.43T INR 353K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.73B 1.11T INR 273K%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.87B 931.67B INR 229K%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.71B 916.53B INR 226K%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 18M%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 13M%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 8M%	97.4	United States
Roche Holding AG SIX: RO	$318.3B 256.25B CHF 7M%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$284.64B 215.59B GBP 7M%	27.6	United Kingdom
Merck & Co., Inc. NYSE: MRK	$274.03B 6M%	15.1	United States

chevron_leftBack